FILE - The logo for Merck appears above a trading post on the floor of the New York Stock Exchange, Thursday, May 1, 2025. (AP Photo/Richard Drew, File) (Richard Drew ...

Growth is driven by rising COPD cases due to smoking and pollution, and enhanced therapeutic options like bronchodilators and biologics. Significant investments are improving diagnosis and treatment.

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that affects millions of people in the United ...

PHILADELPHIA (WPVI) -- COPD is one of the nation's biggest health problems - up to 24 million Americans may suffer from it. Temple Health is involved in trials for an innovative treatment to cut COPD ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new chronic ...